Treatment patterns of gemcitabine-based chemotherapy in patients with de novo and recurrent advanced biliary tract cancer.

被引：0
|
作者：
Dayyani, Farshid
Stirnadel-Farrant, Heide A.
Hu, Jenny
Lin, Yian
Kebede, Nehemiah
Valerio, Stephen J.
Ahn, Daniel H.
机构：
[1] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Orange, CA USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, South San Francisco, CA USA
[5] Mayo Clin, Div Med Oncol, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
281-318-6655; 130-544; 283-237-2581-144; 281-487; 261-566-148; 6; 3; 2; 1614; 3590; 176; 239; 54; 2018; 92; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [1] Gemcitabine-based chemotherapy for advanced biliary tract carcinomas
    Abdel-Rahman, Omar
    Elsayed, Zeinab
    Elhalawani, Hesham
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (04):
  • [2] Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study
    Dayyani, Farshid
    Stirnadel-Farrant, Heide A.
    Hu, Jenny
    Lin, Yian
    Kebede, Nehemiah
    Valerio, Stephen J.
    Ahn, Daniel H.
    CANCERS, 2025, 17 (02)
  • [3] Efficacy and safety of durvalumab and gemcitabine-based chemotherapy combined with or without lenvatinib in advanced biliary tract cancer.
    Ding, Qi
    Sun, Yubei
    Wang, Gang
    Song, Ruipeng
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [4] FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy
    Roussot, Nicolas
    Vincent, Julie
    Palmier, Remi
    Constantin, Guillaume
    Bengrine, Leila
    Fumet, Jean-David
    Ghiringhelli, Francois
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy
    Lee, Sunyoung
    Shroff, Rachna T.
    Makawita, Shalini
    Xiao, Lianchun
    De Armas, Anaemy Danner
    Bhosale, Priya
    Reddy, Kavitha
    Shalaby, Ahmed
    Raghav, Kanwal
    Pant, Shubham
    Wolff, Robert A.
    Javle, Milind
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2229 - 2236
  • [6] Gemcitabine-based chemotherapy in advanced-metastatic and/or unresectable pancreatic cancer.
    Samelis, GF
    Areovimata, A
    Matsiakou, F
    Zografos, G
    Papakostas, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 376S - 376S
  • [7] Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer.
    Nio, K.
    Ueno, H.
    Okusaka, T.
    Morizane, C.
    Hagihara, A.
    Kondo, S.
    Mayahara, H.
    Ito, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Gemcitabine-based Adjuvant Chemotherapy for Patients with Advanced Gallbladder Cancer
    Nakamura, Masafumi
    Nakashima, Hiroshi
    Abe, Toshiya
    Ensako, Takaaki
    Yoshida, Koji
    Hino, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (06) : 3125 - 3129
  • [9] Multicenter phase II trial of axitinib monotherapy for advanced biliary tract cancer refractory to gemcitabine-based chemotherapy
    Okaro, N.
    Ueno, M.
    Morizane, C.
    Yamanaka, T.
    Ojima, H.
    Ozaka, M.
    Sasaki, M.
    Takahara, N.
    Kobayashi, S.
    Morimoto, M.
    Hosoi, H.
    Nakai, Y.
    Ikeda, M.
    Maeno, S.
    Nagashima, F.
    Okusaka, T.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 283 - 283
  • [10] TOURMALINE: A phase 3b study of durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer
    Vogel, Arndt
    He, Aiwu Ruth
    Oh, Do-Youn
    Macarulla, Teresa
    Dane, Aaron
    Nguyen, Binh
    Wetherill, Graham
    Baur, Boris
    Ikeda, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345